Envista Holdings Co. (NYSE:NVST – Get Free Report) CFO Eric D. Hammes acquired 24,532 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the purchase, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
Envista Stock Up 4.2 %
NVST opened at $18.03 on Friday. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of -25.04, a PEG ratio of 14.74 and a beta of 1.31. The firm has a 50 day moving average price of $16.71 and a 200-day moving average price of $19.29. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $33.34. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.34.
Envista (NYSE:NVST – Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). The company had revenue of $633.10 million for the quarter, compared to analysts’ expectations of $646.88 million. Envista had a negative net margin of 4.70% and a positive return on equity of 5.84%. Envista’s quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.43 earnings per share. Equities research analysts forecast that Envista Holdings Co. will post 1.15 earnings per share for the current year.
Institutional Investors Weigh In On Envista
Analysts Set New Price Targets
Several research firms have recently issued reports on NVST. JPMorgan Chase & Co. lowered shares of Envista from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Robert W. Baird dropped their target price on Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Bank of America reduced their price target on Envista from $22.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Thursday, August 8th. Finally, Morgan Stanley downgraded shares of Envista from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $33.00 to $21.00 in a research report on Friday, April 26th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $19.14.
Get Our Latest Stock Analysis on NVST
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Jeff Brown’s Exegesis AI Stock Picks
- Retail Stocks Investing, Explained
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.